about
Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.Potential Antiviral Agents from Marine Fungi: An OverviewCMV: Prevention, Diagnosis and TherapyCytomegalovirus antivirals and development of improved animal modelsCharacterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.Antiviral drug resistance of human cytomegalovirus.Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection.Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.Antiviral drug resistance as an adaptive processFoscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.Detailed polymorphism study on cytomegalovirus DNA polymerase gene to reveal the most suitable genomic targets for quantitative Real-time PCRA model of human cytomegalovirus infection in severe combined immunodeficient mice.Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant.The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipientNovel method based on "en passant" mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations.Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.Testing the susceptibility of human herpesviruses to antivirals.The search for new therapies for human cytomegalovirus infections.Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.DSTP-27 prevents entry of human cytomegalovirus.Letermovir for the management of cytomegalovirus infection.Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase.In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness.Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposureSuccessful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.Assessment of the Human Cytomegalovirus UL97 Gene for Identification of Resistance to Ganciclovir in Iranian Immunosuppressed PatientsRapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance.
P2860
Q24537618-F6015AD6-45A7-4990-9A64-7ECD4DFEAA20Q26800107-1A00A409-71B2-47E1-8C5C-6B2139B1FD20Q26824869-127AB289-F3E4-4F41-A619-A2F05B83F014Q27000998-162A3AEA-96FB-40D5-BD30-B37CC67C55FAQ30363200-EAC4AFFA-2815-4944-9F14-305C25C112A6Q30430427-7A3179EF-A5DC-456C-8873-C44D37A34EF2Q33753996-BB93EE3B-C271-48C3-AF6E-7560A1FB99D0Q33876672-4E65E281-9A82-422E-AB3E-28651391230CQ33878407-7EC5410A-8C1B-46D2-B973-62435CFA99BDQ34034462-71FF9D0E-5FDB-4206-9622-88595A848DB7Q34973821-6ADEF9D5-6438-4014-80EB-28BDA852E2E5Q35270303-0F92F466-E031-4C85-A116-58EB107EE9A4Q35635817-64CBE7EB-1774-431A-80EC-61F091FBCFE8Q36124353-9CCE0DBC-F448-4863-96D6-96537A67AB83Q36177655-2F9F9902-B2B4-4E2D-B8A5-7CF6F6FC5C3BQ36423920-4656E78E-C168-4FBC-884A-75A1D615093DQ37173390-ECE46C2B-F83A-4AB9-B432-E5AA9CE96534Q37261888-575D9DEC-AF74-40B6-BC71-D1A4F5A1132FQ37264338-5A04DE58-B059-469A-AB97-FAB5859CE9E5Q37357122-93360C4E-E44E-411D-ABF6-D8716B19860BQ37446675-69F27997-0534-4F7D-9EB5-C773251DE68EQ37453329-F7239E5E-FFE8-40F4-A476-699842221441Q37477905-BC8B80FE-5B5E-401C-BD39-747C324BCD81Q37628669-EA2BFDB6-2484-4844-BE35-7DCFD61BEC55Q37811458-902D3E98-C36A-4E23-904B-FA8AAEBF6FCCQ38067694-E257AB27-1FD2-4918-BD9B-1B943163E3ACQ38282979-3A8EB775-B6B2-4F95-BAB4-6C842F7D7A93Q38370342-761A5C96-FE04-4DD2-B79D-8FB0FA70E865Q38725677-F54EAB02-D972-45EB-B63D-56D7032E537CQ38779846-0953FDB3-6FE3-439C-9B10-E1F3CBC11C22Q39034745-FAC76C69-7E3F-4172-832C-60754505D5A5Q39044770-5F8DE174-1F50-4D65-AB56-1762A4094403Q39650785-DAC95E44-835E-43B9-ACFA-1C64D6747BB0Q39756225-9DBDF875-0F3D-4993-80AF-A0EBC6330B83Q39834653-9633751B-1DDD-436A-8D60-CF3726D8BBC6Q39949115-A52DCBF0-8F6A-4FB8-BCC7-A6A6878188F8Q40348364-7081A5B7-6034-4A4E-96B7-3D353076CB1DQ40399325-7BF4E05F-F6E0-4D2D-AF8C-B1443F6E4AE6Q40570063-AA9052E3-645F-47D1-A34D-446EDE9AE212Q41070624-B5A36F1B-ABFD-4F9D-9D77-E132C8D790FA
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Human cytomegalovirus resistance to antiviral drugs
@ast
Human cytomegalovirus resistance to antiviral drugs
@en
Human cytomegalovirus resistance to antiviral drugs
@nl
type
label
Human cytomegalovirus resistance to antiviral drugs
@ast
Human cytomegalovirus resistance to antiviral drugs
@en
Human cytomegalovirus resistance to antiviral drugs
@nl
prefLabel
Human cytomegalovirus resistance to antiviral drugs
@ast
Human cytomegalovirus resistance to antiviral drugs
@en
Human cytomegalovirus resistance to antiviral drugs
@nl
P2860
P1476
Human cytomegalovirus resistance to antiviral drugs
@en
P2093
P2860
P304
P356
10.1128/AAC.49.3.873-883.2005
P407
P577
2005-03-01T00:00:00Z